Taisho Pharmaceutical Holdings Co (TSE:4581) Marketable Securities : 円20,296 Mil (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Taisho Pharmaceutical Holdings Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Taisho Pharmaceutical Holdings Co's Marketable Securities for the quarter that ended in Dec. 2023 was 円20,296 Mil.

Taisho Pharmaceutical Holdings Co's annual Marketable Securities increased from Mar. 2021 (円4,017 Mil) to Mar. 2022 (円7,219 Mil) but then declined from Mar. 2022 (円7,219 Mil) to Mar. 2023 (円200 Mil).

Taisho Pharmaceutical Holdings Co Marketable Securities Historical Data

The historical data trend for Taisho Pharmaceutical Holdings Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taisho Pharmaceutical Holdings Co Marketable Securities Chart

Taisho Pharmaceutical Holdings Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Marketable Securities

Get a 7-Day Free Trial

75,900.00

14,089.00

4,017.00

7,219.00

200.00

Taisho Pharmaceutical Holdings Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Marketable Securities	Get a 7-Day Free Trial															7,399.00	200.00	20,231.00	20,278.00	20,296.00

Taisho Pharmaceutical Holdings Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Taisho Pharmaceutical Holdings Co (TSE:4581) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Taisho Pharmaceutical Holdings Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of Taisho Pharmaceutical Holdings Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Taisho Pharmaceutical Holdings Co (TSE:4581) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taisho Pharmaceutical Holdings Co Ltd (TSE:4581) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

TAIPY:USA TAISF:USA

Address

3-24-1 Takada, Toshima-ku, Tokyo, JPN, 170-8655

Website

http://www.taisho-holdings.co.jp

Taisho Pharmaceutical Holding Co Ltd is a specialty and generic drug manufacturing company. The company maintains two operational segments, Self-Medication and Prescription Pharmaceuticals. The vast majority of Taisho's revenue is derived from its Self-Medication segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. The vast majority of sales are generated by sales to external customers in Japan.

Taisho Pharmaceutical Holdings Co (TSE:4581) Headlines

No Headlines